Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
Recruiting now
Conditions studied: Hypertension
In brief
The investigators want to explore the relationship between different configurations of hypertension and the incidence of cardiovascular events by the guidelines reference range and EMINCA recommended reference range. Then the investigators want to enroll twenty research centers and 2200 hypertensions were planned to be collected and followed up in the 12th, 24th, 36th and 48th months after being enrolled in this study. Physical examination, ECG examination, laboratory examination, echocardiography and carotid ultrasound should be taken when baseline and follow-up. Echocardiographic measurement parameters were analyzed and the relationship between the echocardiographic measurement parameters and cardiovascular events and prognosis of hypertension.
Key facts
- Study ID
- NCT05638503
- Run by
- Qilu Hospital of Shandong University
- People needed
- 2200
- Starts
- 2022-05-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2024-04-04
Who can join
Age: 30 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 30-75 years old;
- No antihypertensive drugs were used and three blood pressure measurements were conducted on different days, with systolic blood pressure ≥ 140 mmHg (1 mmHg=0.133 kPa) and/or diastolic blood pressure ≥ 90 mmHg; or have a history of hypertension and are using antihypertensive drugs, even if the blood pressure is lower than 140/90 mmHg;
- Left ventricular ejection fraction was normal (LVEF ≥ 0.5).
- All patients agreed to participate in the experiment and signed the informed consent form.
You may not qualify if…
- Secondary hypertension caused by renal parenchymal diseases, renal vascular diseases, coarctation of aorta and endocrine system diseases;
- Severe cardiovascular and cerebrovascular diseases; heart valve disease; persistent atrial fibrillation and severe arrhythmia; previously undergone cardiovascular disease surgery;
- Abnormal liver function; abnormal renal function and diabetes;
- Pregnant or breastfeeding women;
- Expected survival time due to non-cardiovascular disease<4 years;
- Patients with poor echocardiographic image quality.
Where it is running
- Qilu Hospital of Shandong University — Jinan, Shandong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.